Foresight Group has invested in the digital healthcare provider to accelerate the development of new AI-enabled products.
Regional private equity and infrastructure investment manager Foresight Group has invested £3 million in MyWay Digital Health, a digital healthcare provider that helps manage chronic diseases, specifically diabetes.
Spun out of the University of Dundee in 2017, the firm employs 30 staff across Dundee, Edinburgh and London. The company says that its mission is to improve the lives of individuals living with long-term conditions through cost-effective, data-driven, personalised health technology.
Its suite of products includes diabetes prevention, cardiovascular health, hypertension and weight management.
The firm’s flagship platform, MyWay Diabetes, is a clinically validated digital self-management tool that integrates with NHS systems to provide personalised education, data visualisation, and actionable insights for patients and clinicians. The platform has been adopted across multiple NHS regions and internationally, demonstrating measurable improvements in patient engagement and health outcomes.
Funds raised will be used to accelerate the development of new AI-enabled products, including predictive analytics and personalised care pathways, and expand its commercial footprint to meet growing global demand for scalable digital health solutions.
